Euda Health Holdings Limited - Ordinary Shares EUDA 深 滬
已收盤 09-05 16:00:00 美东时间
1.46
-0.040
-2.67%
華盛通- 最 高1.69
- 今 開1.50
- 成交量 1.73万股
- 最 低 1.435
- 昨 收 1.50
- 總市值 5424.83万
- 52周最高 6.30
- 市盈率 靜 --
- 換手率 0.05%
- 52周最低 1.43
- 委 比 76.47%
- 總股本 3715.64万
- 歷史最高 10.50
- 量 比 0.09
- 振 幅 17.00%
- 歷史最低 0.4334
- 每 手 1
- 風險率 0.65%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Bone Biologics (NASDAQ:BBLG) shares increased by 30.4% to $2.7 during ...
09-04 20:08
EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio
EUDA Health Holdings has secured distribution rights for T-cell immunotherapies developed by Shenzhen Inno in Malaysia, marking its second major move into advanced cell therapy this year. The therapy, priced at USD 8,000 per treatment, aims to enhance accessibility to cutting-edge immunotherapy while addressing high costs in the region. The partnership with Shenzhen Inno and Keylock reflects EUDA's commitment to expanding its healthcare portfolio...
09-04 12:00
EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd
EUDA Health Holdings Limited (NASDAQ: EUDA), a leading non-invasive healthcare provider in Asia, has signed a Letter of Intent (LOI) to potentially acquire Chemokine Pte Ltd, a Singapore-based biotech company specializing in molecular supplements and gene modulating formulations. Chemokine has granted EUDA exclusive worldwide distribution rights for its next-generation immune health supplement, Euda Helixé. founded by molecular medicine researche...
08-28 12:00
EUDA launches gene-modulating supplement; sending shares up premarket
Shares of EUDA Health Holdings (NASDAQ:EUDA) rose 10% in the premarket trade on Tuesday after the company announced that it has secured exclusive global distribution rights for a next-generation immun...
08-26 21:43
EUDA Health Holdings Announces That Its Subsidiary, EUDA Health Pte. Ltd Has Secured Exclusive Global Distribution Rights For A Next-Generation Immune Health Supplement From Chemokine Pte. Ltd
EUDA Health Holdings Limited (NASDAQ:EUDA) ("EUDA" or the "Company"), a leading Singapore-based non-invasive healthcare provider in Asia focused on Singapore, Malaysia, and China, today announced that its wholly-owned
08-26 20:02
EUDA Expands Wellness Product Portfolio With A Next-Generation Immune Health Supplement
EUDA Health Holdings (NASDAQ: EUDA), a Singapore-based non-invasive healthcare provider, has secured exclusive global distribution rights for a next-generation immune health supplement, Euda Helixé, developed by Chemokine Pte. Ltd. The product, leveraging advanced epigenetic technology, aims to enhance metabolism, boost vitality, and support longevity by activating beneficial genes and silencing harmful ones. Initially targeting Singapore, Malays...
08-26 12:00
EUDA Health Holdings Announces COO Resignation
EUDA Health Holdings ( ($EUDA) ) has provided an update. On May 19, 2025, EUDA ...
06-02 20:28
爱创用一物一码，为医美行业乱象“整形”
随着颜值经济和悦己经济的崛起，医美行业成为医疗大健康产业中备受瞩目的领域，前景广阔。据有关数据显示，2023年全球医美市场规模近716亿美元，2025年有望...
04-01 15:22
《中国的芬太尼类物质管控》白皮书发布！外交部回应
本文来自：国新办、外交部 3月4日，国务院新闻办公室发布《中国的芬太尼类物质管控》白皮书。 白皮书指出，近年来，中国高度重视芬太尼类物...
03-04 18:24
格隆汇发布EUDA Health(EUDA.US)首次覆盖报告
We are initiating coverage on EUDA Health Holdings Limited (EUDA.US). EUDA aims...
02-18 22:13
